Search results for SCP1 antibody

SCP1 antibody, Genetex, GTX15087

SCP1 antibody, Genetex, GTX15090

SCP1 antibody, Covalab, Ref 00099389

SCP1 antibody, Covalab, Ref 00099383

Anti-SCP1 antibody, Abcam, AB15090

What is this antibody validated in? Anti-SCP1 antibody (ab15090) is a rabbit polyclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF) in Mouse samples. Trusted by the scientific community Anti-SCP1 (ab15090) was first used in a scientific publication in 2004 and has been cited over 110 times in peer-reviewed journals.

Anti-SCP1 antibody, Abcam, AB217295

Anti-SCP1 antibody [EP7918], Abcam, AB175191

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-SCP1 antibody [RM1177], Abcam, AB322067

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

SCP1 antibody [C2C3], C-term, Genetex, GTX101204

Anti-SCP1 antibody [EPR27085-83], Abcam, AB303520

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .